Covered recipient · General Payments record
FOAD NAHAI
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$30,092.48
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $26,104.17 | 1 |
| Travel and Lodging | $1,127.24 | 7 |
| Food and Beverage | $662.25 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $27,672.31 | 23 |
| REVANCE THERAPEUTICS, INC. | $175.04 | 3 |
| MERZ NORTH AMERICA, INC. | $24.99 | 1 |
| Galderma Laboratories, L.P. | $21.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.26 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094215 | CMS |
| ABBVIE INC. | $205.69 | 02/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105094217 | CMS |
| ABBVIE INC. | $207.26 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105094219 | CMS |
| ABBVIE INC. | $194.87 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105094221 | CMS |
| ABBVIE INC. | $8.66 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094223 | CMS |
| ABBVIE INC. | $207.26 | 02/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105094225 | CMS |
| ABBVIE INC. | $51.96 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094227 | CMS |
| ABBVIE INC. | $8.66 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094229 | CMS |
| ABBVIE INC. | $51.96 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094231 | CMS |
| ABBVIE INC. | $207.26 | 02/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105094233 | CMS |
| ABBVIE INC. | $8.66 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094235 | CMS |
| ABBVIE INC. | $8.66 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094237 | CMS |
| ABBVIE INC. | $7.47 | 03/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105094239 | CMS |
| ABBVIE INC. | $97.43 | 03/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105094241 | CMS |
| ABBVIE INC. | $19.89 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094243 | CMS |
| ABBVIE INC. | $128.37 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094245 | CMS |
| ABBVIE INC. | $26,104.17 | 03/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105094247 | CMS |
| ABBVIE INC. | $24.57 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094249 | CMS |
| ABBVIE INC. | $0.41 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094251 | CMS |
| ABBVIE INC. | $2.73 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094253 | CMS |
| ABBVIE INC. | $89.19 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094255 | CMS |
| ABBVIE INC. | $4.79 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094257 | CMS |
| ABBVIE INC. | $3.13 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094259 | CMS |
| Galderma Laboratories, L.P. | $21.32 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145318012 | CMS |
| MERZ NORTH AMERICA, INC. | $24.99 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146369823 | CMS |
| REVANCE THERAPEUTICS, INC. | $74.46 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147925234 | CMS |
| REVANCE THERAPEUTICS, INC. | $42.34 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147925236 | CMS |
| REVANCE THERAPEUTICS, INC. | $58.24 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147925238 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.